Clinical Trial Update: New Double Epigenetic Regimen in the Treatment of Relapsed or Refractory Acute Myeloid Leukemia [Phase 2]

View source ↗

Summary

A Phase 2 trial update describes a new double epigenetic regimen being studied in relapsed or refractory acute myeloid leukemia, with the study currently active…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Leukemia

Snippet

Sponsor: The First Affiliated Hospital of Soochow University | Conditions: Acute Myeloid Leukemia, Refractory Acute Leukemia | Phase 2 | Status: ACTIVE_NOT_RECRUITING